Erlotinib in the first-line treatment of non-small-cell lung cancer

Manolo D’Arcangelo, Federico Cappuzzo
  • Expert Review of Anticancer Therapy, May 2013, Taylor & Francis
  • DOI: 10.1586/era.13.23

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1586/era.13.23

The following have contributed to this page: Dr Federico Cappuzzo